Showing 701-710 of 23022 results for "".
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
https://reachmd.com/programs/cme/chairpersons-perspective-innovative-approaches-to-ibs-c-personalized-treatment-for-better-outcomes/27169/Join us to discover the impact of IBS-C on patients’ QoL and find out how to apply advances in its treatment & management.Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
https://reachmd.com/programs/cme/time-is-bone-making-the-case-for-early-anabolic-treatment-in-osteoporosis/32806/Anabolics are underused in high-risk osteoporosis. Preventable factors contribute to underuse and poor patient outcomes. You can make a difference!TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
https://reachmd.com/programs/cme/trop2-adcs-for-metastatic-nsclc-setting-the-stage-for-future-use/14416/Are you as excited as we are to see how TROP2-targeted antibody-drug conjugates can help our patients?Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients
https://reachmd.com/programs/Audioabstracts/journal-cystic-fibrosis-efficacy-safety-levofloxacin-inhalation-solution-apt-1026/8217/A study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients.Emergency Contraception
https://reachmd.com/programs/clinicians-roundtable/emergency-contraception/1608/The frantic page came in at 3 AM on Sunday morning. "The condom had just broken." My patient was out of state and wanted the morning after pill. Unfotunately, she gave me the number of a pharmacy that was closed at 3 AM on Sunday morning, so I had to call her back . . . Join us as we learnCancer is Common (And Other Cancer Myths)
https://reachmd.com/programs/clinicians-roundtable/cancer-is-common-and-other-cancer-myths/2375/Levi Garraway, MD, PhD, recent recipient of the NIH Director’s New Innovator Award and assistant professor of medicine at the Harvard Medical School, has been credited with major advances in cancer biology. Dr. Garraway joins host Dr. Gary Kohn to discuss several common myths within our understandinIs Cancer a Disease of the Genome?
https://reachmd.com/programs/clinicians-roundtable/is-cancer-a-disease-of-the-genome/2376/Levi Garraway, MD, PhD, of the Dana Farber Cancer Institute in Boston, is credited with facilitating major advances in our understanding of cancer biology. He discusses the new paradigm of cancer, as a genomic disease which leads to abnormal activation of oncogenes and inactivation of suppressor genInnovations in Less-Invasive Epilepsy Surgery
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/innovations-in-less-invasive-epilepsy-surgery/39963/Recent developments in epilepsy surgery underscore a growing trend toward reduced invasiveness and expanded clinical indications.The NASH Epidemic: Highlights from the AMCP 2023 Symposium
https://reachmd.com/programs/cme/the-nash-epidemic-highlights-from-the-amcp-2023-symposium/14957/Tune in to hear key takeaways and a breakdown of clinical data from a recent satellite symposium focused on the screening and treatment NASH.Severity Assessment: Can You Pin the Stage on the Patient?
https://reachmd.com/programs/cme/severity-assessment-can-you-pin-the-stage-on-the-patient/51481/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.